Mucosal Healing in Crohn’s Disease and Ulcerative Colitis

G&H  How has the definition of mucosal healing evolved? LP-B  For many decades, mucosal healing equaled endoscopic healing. The main change is that, for several years […]

Targeting Mucosal Healing in Crohn’s Disease

  Abstract: The goals of medical treatment for Crohn’s disease are to induce remission and prevent long-term complications. The assessment of disease activity and response to […]

Targeting Mucosal Healing in Crohn’s Disease

Abstract: The goal of medical treatment for Crohn’s disease includes improving patients’ quality of life while reducing the need for hospitalization and surgery. The current medical armamentarium includes 5-aminosalicylates, corticosteroids, immunomodulators, and biologic agents. In the past, response to treatment was measured by clinical improvement in symptoms; however, with the advent of disease-modifying medications, mucosal healing has emerged as an increasingly important goal of therapy. Mucosal healing, or endoscopic remission, is associated with increased rates of clinical remission, fewer hospitalizations, and fewer abdominal surgeries. Both the immunomodulator and biologic classes of medications are effective at inducing mucosal healing. Despite several limitations, mucosal healing has become a desirable and valid measure of disease activity.

Millennium Medical Publishing, Inc